Monroe Capital Corporation Q4 2025 Earnings EPS Surpasses Estimates by Nearly 20 vTv Therapeutics Q1 2026 Earnings EPS Surges to 165 Far Above Estimates Despite No Reported Revenue AGIO Q1 2026 Earnings Narrower Loss Per Share Highlights Improving Cost Management KEP Q4 2025 Earnings EPS Miss Weighs on Shares Amid Cost Pressures ATHR Q1 2026 Earnings Narrowerthanexpected Loss Lifts Shares SOHON Q2 2025 Earnings Preferred Dividend Coverage Reported Positive Amid Quiet Quarter